logo
logo

Latest Financial Updates

Read the latest financial news update from our blog

Userbird: Google Analytics Alternative with Heatmaps,
Userbird: Google Analytics Alternative with Heatmaps,

Userbird Google Analytics Alternative with Heatmaps, Session Recordings and more Userbird...

Admin | Finance | 8 weeks ago

read more
The Future of AI-Driven Risk Mitigation
The Future of AI-Driven Risk Mitigation

AI and generative AI are revolutionizing risk management, replacing standardized, one-size...

Admin | Finance | 8 weeks ago

read more
Verrica Pharmaceuticals Inc. (VRCA) Q2 2025 Earnings Call Transcript
Verrica Pharmaceuticals Inc. (VRCA) Q2 2025 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q2 2025 Earnings Conference Call August 12, 202...

Admin | Finance | 8 weeks ago

read more
BPCL, IRCTC, Samvardhana, Deepak Nitrite Q1 Results Today — Earnings Estimates
BPCL, IRCTC, Samvardhana, Deepak Nitrite Q1 Results Today — Earnings Estimates

Bharat Petroleum Corp., Indian Railway Catering and Tourism Corp., and Samvardhana Mothers...

Admin | Finance | 8 weeks ago

read more
Stock Market Today: All You Need To Know Going Into Trade On Aug. 13
Stock Market Today: All You Need To Know Going Into Trade On Aug. 13

The benchmark equity indices closed for in the red for the second straight day on Tuesday...

Admin | Finance | 8 weeks ago

read more
No stopping ETH, back to US$4600+
No stopping ETH, back to US$4600+

I've posted on the tailwinds for Ether before. Ethereum's price gains are being driven by...

Admin | Finance | 8 weeks ago

read more
Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially (NASDAQ:IRIX)
Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially (NASDAQ:IRIX)

The earnings call insights are compilations of earnings call transcripts and other content...

Admin | Finance | 8 weeks ago

read more
Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs (NASDAQ:PLSE)
Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs (NASDAQ:PLSE)

The earnings call insights are compilations of earnings call transcripts and other content...

Admin | Finance | 8 weeks ago

read more

Join Our Newsletter

join our newsletter to receive update from us